PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
Clinical trial NCT06429696 · RECRUITING
Trial details
- NCT number
- NCT06429696
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-14
- Primary completion
- 2026-04-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.